| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $54,786,358 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS140441 | Unique Role of ASPM in Development of Large and Folded Cerebral Cortex | 000 | 1 | NIH | 7/3/2025 | $680,941 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS142751 | Molecular mechanism of the synapse organizer C1QL3 | 000 | 1 | NIH | 3/17/2025 | $249,750 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS140176 | Developing next-generation RNA inhibitors for stroke therapy | 000 | 1 | NIH | 6/30/2025 | $520,025 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL150362 | RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | 001 | 5 | NIH | 8/12/2025 | $54,511 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL150362 | RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | 000 | 5 | NIH | 2/27/2025 | $490,600 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084992 | Role of NOTCH2 in Articular Inflammation | 000 | 1 | NIH | 5/14/2025 | $404,187 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EB037174 | In situ formed microneedle-like depots for spatiotemporally controlled drug delivery | 000 | 1 | NIH | 6/25/2025 | $208,125 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EB037174 | In situ formed microneedle-like depots for spatiotemporally controlled drug delivery | 001 | 1 | NIH | 9/16/2025 | -$208,124 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AI187932 | Contribution of RpoS to persistence of Borrelia burgdorferi in mammals | 000 | 1 | NIH | 6/27/2025 | $457,875 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 3 | NIH | 2/18/2025 | $369,139 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 001 | 3 | NIH | 6/4/2025 | $28,710 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 000 | 2 | NIH | 2/28/2025 | $489,677 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R24AR084725 | Archiving and Sharing Skeletal Phenotyping Data | 000 | 2 | NIH | 9/2/2025 | $371,323 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R24AR084725 | Archiving and Sharing Skeletal Phenotyping Data | 000 | 2 | NIH | 9/2/2025 | $75,000 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HD114435 | Elucidating the role of FBLL1 in ribosome function during neuronal differentiation | 000 | 2 | NIH | 8/4/2025 | $46,730 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EY035843 | A Novel Mouse Model for Spontaneous and Age-Related Choroidal Neovascularization | 000 | 2 | NIH | 8/4/2025 | $166,500 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U54AG075941 | Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory Project | 002 | 5 | NIH | 8/13/2025 | $2,700,000 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U54AG075941 | Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory Project | 003 | 5 | NIH | 8/26/2025 | $342,784 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK140455 | New Approaches for the treatment of Hypothyroidism | 000 | 2 | NIH | 7/3/2025 | $333,000 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 001 | 4 | NIH | 4/21/2025 | $486,145 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 003 | 4 | NIH | 9/22/2025 | $66,400 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 002 | 4 | NIH | 9/19/2025 | -$12,384 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL167647 | Linkages between HIV/STI prevention and syndemic behaviors in high risk youth: Common factors and unique pathways | 000 | 2 | NIH | 7/18/2025 | $670,683 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 001 | 2 | NIH | 8/26/2025 | $54,384 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 2 | NIH | 1/10/2025 | $489,460 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30AG081093 | Investigating Cellular Senescence at the Single Cell Level | 000 | 3 | NIH | 6/25/2025 | $54,538 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 001 | 5 | NIH | 6/4/2025 | $30,978 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 000 | 5 | NIH | 12/4/2024 | $398,282 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM155240 | Mechanistic Elucidation of Mitochondrial Stress Response in Human Cells | 000 | 2 | NIH | 6/17/2025 | $416,250 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM153326 | Developmental constraints shaping human sex chromosomes and escape from X inactivation | 001 | 2 | NIH | 8/7/2025 | $449,550 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 3 | NIH | 11/1/2024 | $416,250 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 001 | 2 | NIH | 5/16/2025 | $30,439 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 000 | 2 | NIH | 10/28/2024 | $391,357 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL166547 | Perinuclear Ryanodine Receptors and Cardiac Remodeling | 000 | 3 | NIH | 8/5/2025 | $563,303 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG083100 | Increasing successful returns to community living from nursing facilities through the Money Follows the Person program: Mechanisms for improving outcomes for older adults with dementia | 000 | 3 | NIH | 7/15/2025 | $758,885 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31DK136259 | Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters | 000 | 3 | NIH | 8/21/2025 | $45,279 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R4354929 | Autism Secondary Data Analysis Program | 01 | 1 | HRSA | 8/25/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R4354929 | Autism Secondary Data Analysis Program | 00 | 1 | HRSA | 6/30/2025 | $60,000 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R34MH129410 | Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan | 000 | 3 | NIH | 12/19/2024 | $210,089 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 2 | NIH | 1/14/2025 | $677,618 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 002 | 3 | NIH | 6/5/2025 | $55,259 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 001 | 3 | NIH | 12/16/2024 | $497,336 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 000 | 4 | NIH | 3/27/2025 | $236,206 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 4 | NIH | 11/1/2024 | $387,625 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00HD105973 | Mapping inter-cellular trophoblast-decidual signaling to its effects on invasion related maternal-fetal | 000 | 4 | NIH | 9/2/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01EY037664 | Corneal and Schwann cell mechanisms in vesicant injury | 000 | 1 | NIH | 9/10/2025 | $1,467,198 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI194917 | HIV Viral Load Testing Using CRISPR Cascade Signal Amplification | 000 | 1 | NIH | 7/23/2025 | $647,533 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 001 | 2 | NIH | 5/22/2025 | $48,268 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 000 | 2 | NIH | 3/3/2025 | $434,429 |
|
